Product Information
TAVABOROLE 5% TOPICAL SOLUTION is a generic product labeled by Encube Ethicals, Inc., priced at $3.3901 per ML under NDC 21922002012. Its NADAC has been published 241 times since Aug 18, 2021.
FDA first approved this application on Oct 13, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
43.5 mg/mL
Manufacturer
Encube Ethicals, Inc.NDC
21922002012
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TAVABOROLEApproval Type
Generic (ANDA)
FDA Application
ANDA211297FDA Approved
10/13/2020
TE Code
AB
On Market Since
10/19/2020
Pharmacological Classes
Price Statistics
The NADAC for TAVABOROLE 5% TOPICAL SOLUTION has been published 241 times since Aug 18, 2021, and over the history we have for it it has declined 73.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3901 per ML |
|---|---|
| All-time high | $12.6787 (Aug 10, 2022) |
| All-time low | $2.0377 (Jul 17, 2024) |
| 52-week high | $4.0999 |
| 52-week low | $3.3901 |
| Median price | $4.0999 |
| Average price | $5.8844 |
| Largest weekly change | -57.6% (Feb 22, 2023) |
| Weeks tracked | 241 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TAVABOROLE topical solution, 5% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TAVABOROLE topical solution, 5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Oxaborole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAVABOROLE 5% TOPICAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TAVABOROLE 5% TOPICAL SOLUTION, manufactured by Encube Ethicals, Inc., is $3.3901 per ML (NDC 21922002012), effective Sep 30, 2026.
How has the price of TAVABOROLE 5% TOPICAL SOLUTION changed over time?
Over the history we have for it, the NADAC for TAVABOROLE 5% TOPICAL SOLUTION has declined 73.3%. It has been tracked across 241 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for TAVABOROLE 5% TOPICAL SOLUTION?
Since Aug 18, 2021, the NADAC for TAVABOROLE 5% TOPICAL SOLUTION has ranged from a low of $2.0377 (Jul 17, 2024) to a high of $12.6787 (Aug 10, 2022), with a median of $4.0999 per ML.
Are there cheaper alternatives to TAVABOROLE 5% TOPICAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of TAVABOROLE 5% TOPICAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TAVABOROLE 5% TOPICAL SOLUTION?
TAVABOROLE 5% TOPICAL SOLUTION (NDC 21922002012) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.